Nurix Therapeutics (NRIX) Shares Outstanding: 2019-2025
Historic Shares Outstanding for Nurix Therapeutics (NRIX) over the last 6 years, with Aug 2025 value amounting to $76.9 million.
- Nurix Therapeutics' Shares Outstanding rose 14.59% to $76.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $76.9 million, marking a year-over-year increase of 14.59%. This contributed to the annual value of $75.9 million for FY2024, which is 55.73% up from last year.
- Nurix Therapeutics' Shares Outstanding amounted to $76.9 million in Q3 2025, which was up 0.57% from $76.4 million recorded in Q2 2025.
- In the past 5 years, Nurix Therapeutics' Shares Outstanding ranged from a high of $76.9 million in Q3 2025 and a low of $39.1 million during Q1 2021.
- Its 3-year average for Shares Outstanding is $61.7 million, with a median of $64.4 million in 2024.
- Data for Nurix Therapeutics' Shares Outstanding shows a peak YoY spiked of 1,070.75% (in 2021) over the last 5 years.
- Over the past 5 years, Nurix Therapeutics' Shares Outstanding (Quarterly) stood at $44.7 million in 2021, then rose by 5.62% to $47.2 million in 2022, then grew by 3.28% to $48.7 million in 2023, then skyrocketed by 55.73% to $75.9 million in 2024, then rose by 14.59% to $76.9 million in 2025.
- Its Shares Outstanding stands at $76.9 million for Q3 2025, versus $76.4 million for Q2 2025 and $76.2 million for Q1 2025.